Psyence Biomedical (Psyence Biomedical) EV-to-EBIT : (As of Apr. 30, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Psyence Biomedical's Enterprise Value is $12.99 Mil. Psyence Biomedical does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Psyence Biomedical's EV-to-EBIT at this moment.

The historical rank and industry rank for Psyence Biomedical's EV-to-EBIT or its related term are showing as below:

PBM' s EV-to-EBIT Range Over the Past 10 Years
Min: -14.7 Med: 0 Max: 0
Current: -4.16

PBM's EV-to-EBIT is ranked worse than
100% of 440 companies
in the Biotechnology industry
Industry Median: 8.18 vs PBM: -4.16

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Psyence Biomedical's Enterprise Value for the quarter that ended in Mar. 2023 was $0.00 Mil. Psyence Biomedical does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Psyence Biomedical's Earnings Yield (Joel Greenblatt) % at this moment.

Psyence Biomedical EV-to-EBIT Historical Data

The historical data trend for Psyence Biomedical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical EV-to-EBIT Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

EV-to-EBIT

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
EV-to-EBIT	-	-	-

Competitive Comparison of Psyence Biomedical's EV-to-EBIT

For the Biotechnology subindustry, Psyence Biomedical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's EV-to-EBIT falls into.

Psyence Biomedical EV-to-EBIT Calculation

Psyence Biomedical's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	12.990	/
	=

Psyence Biomedical (NAS:PBM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Psyence Biomedical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2023 )	=	EBIT	/	Enterprise Value (Q: Mar. 2023 )
	=		/	0
	=	%

Psyence Biomedical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024